{"organizations": [], "uuid": "e1de4f52ecff8dff393caeeb9f8ff5a5357215c5", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.cnbc.com", "main_image": "https://fm.cnbc.com/applications/cnbc.com/resources/img/editorial/2018/05/15/105210388-3ED2-MM-Block-E-051518.600x400.jpg", "site_section": "http://www.cnbc.com/id/100004038/device/rss/rss.html", "section_title": "Latest Video", "url": "https://www.cnbc.com/video/2018/05/15/cramers-lightning-round-take-a-pass-on-bristol-myers-squibb-shares.html", "country": "US", "domain_rank": 767, "title": "Cramer's lightning round: Take a pass on Bristol-Myers Squibb shares for now", "performance_score": 0, "site": "cnbc.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-05-16T01:59:00.000+03:00", "replies_count": 0, "uuid": "e1de4f52ecff8dff393caeeb9f8ff5a5357215c5"}, "author": "", "url": "https://www.cnbc.com/video/2018/05/15/cramers-lightning-round-take-a-pass-on-bristol-myers-squibb-shares.html", "ord_in_thread": 0, "title": "Cramer's lightning round: Take a pass on Bristol-Myers Squibb shares for now", "locations": [], "entities": {"persons": [{"name": "cramer", "sentiment": "negative"}, {"name": "jim cramer", "sentiment": "negative"}], "locations": [], "organizations": [{"name": "bristol-myers squibb", "sentiment": "negative"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Cramer's lightning round: Take a pass on Bristol-Myers Squibb shares for now 9 Hours Ago Jim Cramer fires off his take on callers' favorite stocks, including a biopharmaceutical play facing a rival.", "external_links": [], "published": "2018-05-16T01:59:00.000+03:00", "crawled": "2018-05-16T02:29:55.047+03:00", "highlightTitle": ""}